Adial Pharmaceuticals Inc.

ADIL | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.40

-$0.46 (-9.47%)

At close: Sep 21, 2026, 4:00 PM ET

$4.48

+$0.08 (+1.82%)

Pre-market: Sep 22, 2026, 7:48 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	141	n/a	141	n/a	141	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	-141	n/a	-141	n/a	-141	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-52.03M	-2M	-1.89M	-1.76M	-1.88M	-2.27M	-1.94M	-2.21M	-2.29M	-1.85M	-1.78M	-1.36M	-1.48M	-2.27M	-2.6M	-2.55M	-3.24M	-3.06M	-5.98M	-4.06M	-4.4M	-4.84M
Interest Income	58K	47.06K	42.61K	47.86K	23.75K	35.35K	53.76K	50.69K	51.4K	22.8K	11.23K	10.24K	19.43K	28.89K	47.82K	3.47K	6.93K	5.12K	2.2K	2.86K	1.18K	295
Pretax Income	-51.99M	-2.02M	-2M	-1.79M	-1.96M	-2.23M	-2.07M	-2.19M	-2.46M	-6.48M	-1.9M	-1.35M	-1.51M	-2.24M	-2.55M	-2.55M	-3.24M	-2.91M	-5.92M	-4.32M	-4.44M	-4.83M
Net Income	-51.99M	-2.02M	-2M	-1.79M	-1.96M	-2.23M	-2.07M	-2.19M	-2.46M	-6.48M	-1.92M	-1.38M	1.09M	-2.91M	-2.87M	-3.11M	-3.85M	-2.91M	-5.83M	-4.32M	-4.44M	-4.83M
Selling & General & Admin	5.4M	1.57M	1.27M	1.24M	1.15M	1.52M	1.21M	1.18M	1.27M	1.39M	1.52M	1.15M	1.05M	1.9M	2.07M	1.86M	2.56M	2.46M	2.05M	2.37M	2.08M	2.79M
Research & Development	440K	432.53K	619.4K	521.07K	732.32K	746.89K	730.79K	1.03M	1.01M	454.28K	264.44K	207.13K	429.9K	365.62K	531.84K	696.07K	679.97K	596.34K	2.33M	1.69M	2.32M	2.05M
Other Expenses	46.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0	1.59M	0	0	0
Operating Expenses	52.03M	2M	1.89M	1.76M	1.88M	2.27M	1.94M	2.21M	2.29M	1.85M	1.78M	1.36M	1.48M	2.27M	2.6M	2.55M	3.24M	3.06M	5.98M	4.06M	4.4M	4.84M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	14.89K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-141	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	19.38K	19.03K	22.23K	18.94K	18.21K
Cost & Expenses	52.03M	2M	1.89M	1.76M	1.88M	2.27M	1.94M	2.21M	2.29M	1.85M	1.78M	1.36M	1.48M	2.27M	2.6M	2.55M	3.24M	3.06M	5.98M	4.06M	4.4M	4.84M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-94.08K	n/a	n/a	n/a
Shares Outstanding (Basic)	4.62M	1.37M	1.11M	886.85K	424.91K	743.55K	743.55K	233.43K	167.31K	118.16K	66.54K	47.14K	45.26K	42.34K	42.7K	41.16K	38.91K	37.04K	32.85K	31.76K	28.14K	25.46K
Shares Outstanding (Diluted)	4.62M	1.37M	1.11M	886.85K	424.91K	743.55K	743.55K	233.43K	167.31K	118.16K	66.54K	47.14K	45.26K	42.34K	42.7K	41.16K	38.91K	37.04K	33.22K	31.76K	28.14K	25.46K
EPS (Basic)	-11.25	-1.48	-1.80	-2	-4.50	-8.50	-2.75	-9.50	-14.75	-54.75	-28.75	-29.50	24	-68.25	-67.25	-73.75	-99.25	-74.50	-177.50	-136	-157.75	-189.75
EPS (Diluted)	-11.25	-1.48	-1.80	-2	-4.50	-8.50	-2.75	-9.50	-14.75	-54.75	-28.75	-29.50	24	-68.25	-67.25	-73.75	-99.25	-74.50	-175.50	-136	-157.75	-189.75
EBITDA	-51.99M	-2.02M	-2M	-1.79M	-1.96M	-2.23M	-2.07M	-2.19M	-2.46M	-6.48M	-1.9M	-1.35M	-1.51M	-2.24M	-2.55M	-2.55M	-3.23M	-2.91M	-4.38M	-4.32M	-4.44M	-4.84M
EBIT	-51.99M	-2.02M	-2M	-1.79M	-1.96M	-2.23M	-2.07M	-2.19M	-2.46M	-6.48M	-1.9M	-1.35M	-1.51M	-2.24M	-2.55M	-2.55M	-3.24M	-2.91M	-4.39M	-4.32M	-4.44M	-4.84M
Depreciation & Amortization	n/a	141	142	141	141	141	141	142	141	141	141	141	141	141	141	141	2.07K	2.07K	4.01K	141	2.07K	803